SPOM - SPO Global Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0541
-0.0061 (-10.06%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.0602
Open0.0632
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0541 - 0.0633
52 Week Range0.0113 - 0.6800
Volume364,381
Avg. Volume1,637,000
Market Cap74,574
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-9.9260
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.75
  • GlobeNewswire

    SPO Global’s subsidiary Gerpang Healthcare Group and Qingdao Fuyutang Health Development Ltd. Announce Partnership

    SHANDONG, China, March 10, 2020 -- SPO Global, Inc. (OTC Markets: SPOM) (the “Company”), is pleased to announce a partnership with QingDao Fuyutang Health Development.

  • GlobeNewswire

    SPO Global’s subsidiary Gerpang Healthcare Group and International Health Technologies announce partnership

    SPO Global, Inc. (OTC Markets: SPOM) (the “Company”), is pleased to announce a partnership with International Health Technologies. Gerpang Healthcare Group and International Health Technologies have signed an exclusive partnership authorizing Shandong Gerpang Biotechnology Co., Ltd. to apply for the certification of IHT devices of National Medical Products Administration on behalf of International Health Technologies. International Health Technologies will provide all necessary assistance to GP in the application process.

  • GlobeNewswire

    CORRECTION — SPO Global and Gerpang Healthcare Group Complete Merger Agreement

    SPO Global, Inc. (OTC Markets: SPOM) (the “Company”), has completed its previously announced merger with Gerpang Healthcare Group (“Gerpang”) of Shandong, China. The acquisition closed on February 19, 2020, and, as previously discussed, all officers and directors of SPO Global have been replaced by the management of Gerpang. Mr. Lu Fengyou has been appointed CEO and Mr. Liangjian Peng has been appointed Secretary.

  • GlobeNewswire

    SPO Global and Gerpang Healthcare Group Announce Definitive Merger Agreement

    SPO Global, Inc. (OTC Markets: SPOM) (the “Company”), is excited to announce the company has signed a definitive agreement to acquire Gerpang Healthcare Group (“Gerpang”) of Shandong, China. Gerpang Healthcare Group (www.gerpanghealthcare.com), is located in Jinan Pharma Valley Industrial Park, High-tech District. The main business scope of Gerpang includes bio-pharmaceutical R&D, development and sales of medical informatization software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplement, medicine, as well as agents and sales of medical equipment supplies.

  • GlobeNewswire

    Max Boscaino, CEO of SPO Global, Inc., is Featured in an Exclusive New Audio Interview at SmallCapVoice.com, Inc.

    SmallCapVoice.com, Inc. and SPO Global, Inc. (“SPO Global” or the “Company”) (OTC Pink: SPOM), today announced that the Company is featured in a new audio interview at SmallCapVoice.com, Inc. Max Boscaino, CEO of SPO Global, Inc. called in to SmallCapVoice.com to go over his Company’s business model, markets they serve, his background in the wine industry, the 2019 goals for the company and more.